Recordati Rare Diseases now holds Isturisa® European MA

NEXT STORY
Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
PREV STORY
TRILLIUM THERAPEUTICS PROVIDES BUSINESS UPDATE IN RESPONSE TO THE COVID-19 PANDEMIC
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

More than 1,200 Groups, Business, and Individuals Call on President Biden to Impose Immediate Moratorium on BLM’s Mass Roundups of Wild Horses and Burros

author_avatar
NASDAQ Market News

Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients

author_avatar
NASDAQ Market News

Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020

author_avatar
NASDAQ Market News